Shanghai Baixin'an Biotechnology

Developer of coronary stent system

placePudong, Shanghai, China calendar_todayFounded 2014 groups58 employees language bio-heart.com

Innovation

6 patent families (1 granted) — focus: Human necessities; filing pace dormant. Cited 27 times.

YearFilings
20156

Investor mix

6 investors on record; lead investors include Shanghai Zhangjiang Technology Venture Capital, CD Capital, Qianhai Ark Asset Management, Yuanbio Venture Capital.

Investor typeCountShare
Venture capital350%
Private equity233%
Other / undisclosed117%
Coming soon